Status:
COMPLETED
Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens
Lead Sponsor:
Bayer
Conditions:
Ovulation Inhibition
Eligibility:
FEMALE
18-35 years
Phase:
PHASE2
Brief Summary
The aim of the study is to investigate the ovulation inhibition of two 4-phasic oral contraceptive regimens.
Eligibility Criteria
Inclusion
- Healthy women willing to use non-hormonal methods of contraception
Exclusion
- Women with any contraindication for oral contraceptive use, for example but not limited to: presence or history of venous or arterial thrombotic / thrombembolic events, hypertension, presence or history of severe hepatic disease
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2004
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT00805415
Start Date
March 1 2003
End Date
February 1 2004
Last Update
July 15 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dinox GmbH Berlin
Berlin, State of Berlin, Germany, 10115
2
Dinox B.V.
Groningen, Netherlands, 9713 GZ